Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TH-302 Monotherapy in Advanced Biliary Tract Cancer
NCT02433639Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of evofosfamide in biliary tract cancer (BTC), sponsored by Seoul National University Hospital. Started Apr 2015; status: completed.
02
Drugs
evofosfamide
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT02433639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433639.